Economic evaluation of proximal intestinal mucosal ablation in insulin-requiring type 2 diabetes: cost-effectiveness and price threshold analysis from a UK NHS perspective with comparison to semaglutide
B. Norton
First-in-human study of proximal intestinal mucosal ablation (PIMA) for the treatment of inadequately controlled type 2 diabetes
B. Norton
Sphincter of oddi dysfunction and functional biliary pain syndrome: A UK tertiary centre experience
D. Sriranganathan
Evaluating Proximal Intestinal Mucosal Ablation as a Repeat Endoscopic Therapy for Type 2 Diabetes
B. Norton
Evaluation of the Predictive Validity of an Endoscopic Ultrasound Virtual Reality Simulator for Trainee Endosonographers
D. Sriranganathan
Evolution of Gastric Outlet Obstruction Management: Insights from a UK Tertiary Centre
A. Marrinan
Ketamine cholangiopathy: A UK tertiary centre experience
D. Sriranganathan
North Central London Acute Severe Pancreatitis Network: A One-Year Review of a Collaborative Two-Centre Referral Model
D. Sriranganathan
Procedural Learning Curve For Proximal Intestinal Mucosal Ablation (PIMA) Using A Novel Through-The-Scope Radiofrequency Vapor Ablation Catheter
B. Norton
Proximal intestinal mucosal ablation (PIMA) enables discontinuation of exogenous insulin in type 2 diabetes: final results from the STEAM-IE trial
B. Norton
Antegrade cholangioscopy: A single-centre experience